Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast - No correlation

被引:20
作者
DouglasJones, AG
Navabi, H
Morgan, JM
Jasani, B
机构
[1] Department of Pathology, University of Wales, College of Medicine, Heath, Cardiff, South Wales, CF4 4XW, Heath Park
关键词
p53; metallothionein; duct carcinoma of breast; DCIS; immunohistochemistry;
D O I
10.1007/s004280050046
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Immunocytochemically detectable MT and p53 have been found more commonly in comedo DCIS of the breast with high-grade cytology. The aim of this study is to confirm these findings and to investigate the relationship between MT and p53 in a single large series of cases of DCIS of the breast. To this end, 127 cases of DCIS were classified histologically according to architecture, cytonuclear differentiation (grade), presence and extent of intraduct necrosis, and using the Van Nuys system. Sections were immunostained for p53 and MT (E9) using established techniques, and the extent and intensity of staining were assessed semi-quantitively. The results confirmed that there was generally more MT and p53 positivity in poorly differentiated (grade 3) DCIS with extensive necrosis and that MT expression was greater in grade 2 lesions than p53 expression. However, overall there was no statistically significant correlation between p53 and MT staining. The results indicate that MT and p53 overexpression may arise from independent mechanisms in early breast neoplasia.
引用
收藏
页码:373 / 379
页数:7
相关论文
共 30 条
  • [1] IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN MAMMARY-CARCINOMA - AN IMPORTANT NEW INDEPENDENT INDICATOR OF PROGNOSIS
    BARNES, DM
    DUBLIN, EA
    FISHER, CJ
    LEVISON, DA
    MILLIS, RR
    [J]. HUMAN PATHOLOGY, 1993, 24 (05) : 469 - 476
  • [2] NONINVASIVE DUCTAL CARCINOMA OF THE BREAST - THE RELEVANCE OF HISTOLOGIC CATEGORIZATION
    BELLAMY, COC
    MCDONALD, C
    SALTER, DM
    CHETTY, U
    ANDERSON, TJ
    [J]. HUMAN PATHOLOGY, 1993, 24 (01) : 16 - 23
  • [3] IMMUNOHISTOCHEMICAL DEMONSTRATION OF METALLOTHIONEIN IN NORMAL HUMAN BREAST-TISSUE AND BENIGN AND MALIGNANT BREAST-LESIONS
    BIER, B
    DOUGLASJONES, A
    TOTSCH, M
    DOCKHORNDWORNICZAK, B
    BOCKER, W
    JASANI, B
    SCHMID, KW
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (03) : 213 - 221
  • [4] CHERIAN MG, 1993, CANCER RES, V53, P922
  • [5] METALLOTHIONEIN EXPRESSION IN DUCT CARCINOMA IN-SITU OF THE BREAST
    DOUGLASJONES, AG
    SCHMID, KW
    BIER, B
    HORGAN, K
    LYONS, K
    DALLIMORE, ND
    MONEYPENNY, IJ
    JASANI, B
    [J]. HUMAN PATHOLOGY, 1995, 26 (02) : 217 - 222
  • [6] LOCALIZATION OF METALLOTHIONEIN IN BREAST CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY
    FRESNO, M
    WU, WY
    RODRIGUEZ, JM
    NADJI, M
    [J]. VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1993, 423 (03) : 215 - 219
  • [7] IMMUNOHISTOCHEMICAL DETECTION OF METALLOTHIONEIN IN PRIMARY BREAST CARCINOMAS AND THEIR AXILLARY LYMPH-NODE METASTASES
    HAERSLEV, T
    JACOBSEN, K
    NEDERGAARD, L
    ZEDELER, K
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 1994, 190 (07) : 675 - 681
  • [8] HAINAUT P, 1993, CANCER RES, V53, P1739
  • [9] P53 IN TUMOR PATHOLOGY - CAN WE TRUST IMMUNOHISTOCHEMISTRY - REVISITED
    HALL, PA
    LANE, DP
    [J]. JOURNAL OF PATHOLOGY, 1994, 172 (01) : 1 - 4
  • [10] HALL PA, 1993, ONCOGENE, V8, P203